References
- Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004; 27:305-18.10.1016/j.cimid.2004.03.00415225981
- Steverding D. The history of leishmaniasis. Parasit Vectors. 2017; 10: 82. 10.1186/s13071-017-2028-5.28202044
- Murray H W, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet. 2005; 366:1561-77.1625734410.1016/S0140-6736(05)67629-5
- Majeed B, Sobel J, Nawar, A, Badri S, Muslim H. The persisting burden of visceral leishmaniasis in Iraq: data of the National Surveillance System, 1990–2009. Epidemiol Infect. 2013; 141:443-6.10.1017/S095026881200055622475358
- Salam N, Al-Shaqha WM, Azzi A. Leishmaniasis in the Middle East: incidence and epidemiology. PLoS Negl Trop Dis. 2014; 8:e3208. 10.1371/journal.pntd.0003208.25275483
- AlSamarai, AM, AlObaidi, HS. Cutaneous leishmaniasis in Iraq. J Infect Dev Ctries. 2009; 3:123-9.19755742
- Korzeniewski K. Health hazards in Iraq. Lekarz Wojskowy [Military Doctor]. 2005; 81:176-80.
- 8.World Health Organization, WHO Leishmaniasis Resource: Iraq. Available at: http://www.who.int/leishmaniasis/resources/IRAQ.pdf. Accessed 29 August 2014.
- Ashford, RW. The leishmaniases as emerging and reemerging zoonoses. Int J Parasitol. 2000; 30:1269-81.1111325410.1016/S0020-7519(00)00136-3
- Gramiccia M, Gradoni L. The current status of zoonotic leishmaniases and approaches to disease control. Int J Parasitol. 2005; 35:1169-80.1616234810.1016/j.ijpara.2005.07.001
- CSO. Central Statistical Organization. Annual Report. Available at: http://www.cosit.gov.iq/en/home
- Nazzaro G, Rovaris M, Veraldi S. Leishmaniasis: a disease with many names. JAMA Dermatol. 2014; 150: 1204.10.1001/jamadermatol.2014.101525389793
- Kumar R, Bumb RA, Ansari NA, Mehta RD, Salotra P. Cutaneous leishmaniasis caused by Leishmania tropica in Bikaner, India: parasite identification and characterization using molecular and immunologic tools. Am J Trop Med Hyg. 2007; 76:896-901.17488912
- Roberts CW, Walker W, Alexander J. Sex-associated hormones and immunity to protozoan parasites. Clin Micobiol Rev. 2001; 14:476-88.10.1128/CMR.14.3.476-488.2001
- Rahi AA. Cutaneous leishmaniasis at Wasit governorate. Baghdad Sci J. 2011; 8:286-8.
- Mendonça SC. Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery. Parasite Vectors. 2016; 9:492. 10.1186/s13071-016-1777-x.
- Karami M, Doudi M, Setorki M. Assessing epidemiology of cutaneous leishmaniasis in Isfahan, Iran. J Vector Borne Dis. 2013; 50:30-7.23703437
- Abdellatif, MZ, El-Mabrouk K, Ewis AA. An epidemiological study of cutaneous leishmaniasis in Al-jabal Al-gharbi, Libya. Korean J. Parasitol. 2013; 51: 75-84.10.3347/kjp.2013.51.1.75
- Nawaratna SS, Weilgama DJ, Wijekoon CJ, Dissanayake M, Rajapaksha K. Cutaneous leishmaniasis, Sri Lanka. Emerg Infect Dis. 2007; 13: 1068-70.10.3201/eid1307.06077318214182
- Hunter PR. Climate change and waterborne and vector borne disease. J Appl Microbiol. 2003; 94:37-46.10.1046/j.1365-2672.94.s1.5.x
- Stoops CA, Heintshcel B, El Hossary S, Kaldas RM, Obenauer PJ, Farooq M, et al. Sand fly surveillance and control on Camp Ramadi, Iraq, as part of a leishmaniasis control program. J Vector Ecol. 2013; 38: 411-4.10.1111/j.1948-7134.2013.12059.x24581374